Clinical Trial Update: Combination Vaccination and Broadly Neutralising Antibody Therapy in HIV [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial combining an HIV vaccine with broadly neutralising antibody therapy is currently recruiting, sponsored by the University of Oxford.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Broadly Neutralising Antibody Therapy
• Combination Vaccination

Snippet

Sponsor: University of Oxford | Conditions: HIV | Phase 2 | Status: RECRUITING